Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Kite, A Gilead Company · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
relapsed/refractory diffuse large b-cell lymphoma (dlbcl), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 803479
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.